Cytisin amidophosphate - The new cytoprotector

Zhaxybay Zhumadilov, Talgat Nurgozhin, Alexandr Gulyaev, Sabira Zhaugasheva, Arystan Gazaliyev, Bakytgul Ermekbayeva, Guinara Abuova, Almas Kenessary

Research output: Contribution to journalArticlepeer-review


This article describes the results of a clinical study of O, O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.

Original languageEnglish
Pages (from-to)45-49
Number of pages5
JournalHiroshima Journal of Medical Sciences
Issue number3
Publication statusPublished - Sep 1 2012


  • Acute toxic hepatitis
  • Cytoprotector

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cytisin amidophosphate - The new cytoprotector'. Together they form a unique fingerprint.

Cite this